Compound Reference

MK-677 (Oral 25 mg)

Ibutamoren — an orally-active ghrelin-receptor agonist

GH secretagogueEvidence: human trials (not approved)RUO · WADA-prohibited
Research Use Only. Not FDA-approved; sold only as a research chemical. Many performance-adjacent peptides are also WADA-prohibited for tested athletes. Educational only — not medical advice.

What it is

MK-677 (ibutamoren) is an orally active, long-acting ghrelin-receptor agonist — unusual for being a non-peptide small molecule that raises GH/IGF-1.

Proposed mechanism

Sustained GHS-R agonism raises GH and IGF-1 around the clock; because it's oral and long-acting it behaves differently from injectable pulsatile GHRPs.1 Water retention and insulin-sensitivity effects are noted.

State of the evidence

Regulatory & status

References

  1. GH secretagogues incl. ibutamoren (review). rco2.9
  2. Ghrelin pathway (review). PMC5412382

Explore the full library & 75-compound reference →

For educational and research purposes only. This content is not medical advice. Compounds referenced are research use only and not intended to diagnose, treat, cure, or prevent any disease. Free Peptide University does not sell compounds.